Importer of Controlled Substances Application: R & D Systems, Inc., 49580-49581 [2018-21334]

Download as PDF 49580 Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices The companies listed below applied to be registered as importers of various basic SUPPLEMENTARY INFORMATION: classes of controlled substances. Information on previously published notices are listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Company FR Docket AMRI Rensselaer, Inc ............................................................................................................................................. S&B Pharma, Inc .................................................................................................................................................... Cerilliant Corporation .............................................................................................................................................. Shertech Laboratories, LLC .................................................................................................................................... Fresenius Kabi USA, LLC ....................................................................................................................................... VHG Labs DBA LGC Standards ............................................................................................................................. Catalent Pharma Solutions, LLC ............................................................................................................................ Fisher Clinical Services, Inc .................................................................................................................................... Anderson Brecon, Inc ............................................................................................................................................. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies. Dated: September 20, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–21354 Filed 10–1–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: R & D Systems, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 1, 2018. Such persons may also file a written request for a hearing on the application on or before November 1, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearings must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearings should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register DATES: 83 83 83 83 83 83 83 83 83 amozie on DSK3GDR082PROD with NOTICES1 Jkt 247001 PO 00000 Frm 00051 Fmt 4703 April 9, 2018. July 5, 2018. July 16, 2018. July 23, 2018. July 23, 2018. July 23, 2018. July 23, 2018. July 23, 2018. August 1, 2018. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 9, 2018, R & D Systems, Inc., 614 McKinley Place NE, Minneapolis, Minnesota 55413–5541 applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Drug code Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 3,4-Methylenedioxymethamphetamine ............................................................................................................................ Dimethyltryptamine .......................................................................................................................................................... Psilocyn ........................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Cocaine ............................................................................................................................................................................ 17:16 Oct 01, 2018 15176 31421 32906 34879 34878 34875 34874 34879 37525 Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). Controlled substance VerDate Sep<11>2014 FR FR FR FR FR FR FR FR FR Published Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1 1248 7118 7297 7360 7370 7391 7405 7435 7438 2270 7471 9041 Schedule I I I I I I I I I II II II Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices The company plans to import bulk active controlled substances for distribution to its customers for research and analytical purposes. In reference to drug codes marihuana (7360) and tetrahydrocannabinols (7370) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. Dated: September 20, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–21336 Filed 10–1–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Dated: September 20, 2018. John J. Martin, Assistant Administrator. Office of Justice Programs [FR Doc. 2018–21334 Filed 10–1–18; 8:45 am] Notice of Charter Renewal of the Coordinating Council on Juvenile Justice and Delinquency Prevention [OJP (OJJDP) Docket No. 1751] BILLING CODE 4410–09–P Coordinating Council on Juvenile Justice and Delinquency Prevention, Justice. ACTION: Notice of Charter Renewal. AGENCY: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] ACTION: Notice of registration. The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as an importer of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. SUMMARY: Company FR docket Published Ultra Scientific Inc. 83 FR 37525 August 1, 2018. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for VerDate Sep<11>2014 17:16 Oct 01, 2018 Jkt 247001 Notice that the charter of the Coordinating Council on Juvenile Justice and Delinquency Prevention has been renewed. FOR FURTHER INFORMATION CONTACT: Visit the website for the Coordinating Council at www.juvenilecouncil.gov or contact Jeff Slowikowski, Designated Federal Official (DFO), Office of Juvenile Justice and Delinquency Prevention, by telephone at (202) 616–3646 (not a tollfree number) or via email: jeff.slowikowski@usdoj.gov. SUPPLEMENTARY INFORMATION: This Federal Register Notice notifies the public that the Charter of the Coordinating Council on Juvenile Justice and Delinquency has been renewed in accordance with the Federal Advisory Committee Act, Section 14(a)(1). The renewal Charter was signed by U.S. Attorney General Jefferson B. Sessions on June 29, 2018. One can obtain a copy of the renewal Charter by accessing the Coordinating Council on Juvenile Justice and Delinquency Prevention’s website at www.juvenilecouncil.gov. SUMMARY: Importer of Controlled Substances Registration amozie on DSK3GDR082PROD with NOTICES1 schedule I or II controlled substances to the above listed company. Jeff Slowikowski, Senior Advisor to the Coordinating Council on Juvenile Justice and Delinquency Prevention, Office of Juvenile Justice and Delinquency Prevention. [FR Doc. 2018–21379 Filed 10–1–18; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Parole Commission Sunshine Act Meetings Record of Vote of Meeting Closure (Pub. L. 94–409) (5 U.S.C. 552b) PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 49581 I, Patricia K. Cushwa, of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 1:30 p.m., on Wednesday, September 26, 2018 at the U.S. Parole Commission, 90 K Street NE, Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss original jurisdiction cases pursuant to 28 CFR 2.25. and 28 CFR 2.68(i)(1) Two Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Patricia K. Cushwa and Charles T. Massarone. In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Dated: September 26, 2018. Patricia K. Cushwa, Acting Chairperson, U.S. Parole Commission. [FR Doc. 2018–21566 Filed 9–28–18; 4:15 pm] BILLING CODE 4410–31–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (18–072)] Notice of Intent To Grant Exclusive Term License National Aeronautics and Space Administration. ACTION: Notice of intent to grant an exclusive term license. AGENCY: NASA hereby gives notice of its intent to grant an exclusive term license in the United States to practice the invention described and claimed in U.S. Patent No. 9,749,342 entitled, ‘‘System and Method for Detecting Unauthorized Device Access by Comparing Multiple Independent Spatial-Time Data Sets from Other Devices’’ to Equator Corporation, having its principal place of business in Stafford, VA. DATES: The prospective exclusive license may be granted unless NASA receives written objections, including evidence and argument October 17, 2018, that establish that the grant of the license would not be consistent with the requirements regarding the licensing of federally owned inventions as set forth SUMMARY: E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49580-49581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21334]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: R & D Systems, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before November 1, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before November 1, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearings must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearings should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. Comments and requests for hearings on 
applications to import narcotic raw material are not appropriate. 72 FR 
3417, (January 25, 2007).

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on April 
9, 2018, R & D Systems, Inc., 614 McKinley Place NE, Minneapolis, 
Minnesota 55413-5541 applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone)..            1248  I
JWH-018 (also known as AM678) (1-Pentyl-3-           7118  I
 (1-naphthoyl)indole).
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                 7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
Marihuana................................            7360  I
Tetrahydrocannabinols....................            7370  I
4-Bromo-2,5-dimethoxyamphetamine.........            7391  I
3,4-Methylenedioxymethamphetamine........            7405  I
Dimethyltryptamine.......................            7435  I
Psilocyn.................................            7438  I
Pentobarbital............................            2270  II
Phencyclidine............................            7471  II
Cocaine..................................            9041  II
------------------------------------------------------------------------


[[Page 49581]]

    The company plans to import bulk active controlled substances for 
distribution to its customers for research and analytical purposes. In 
reference to drug codes marihuana (7360) and tetrahydrocannabinols 
(7370) the company plans to import a synthetic cannabidiol and a 
synthetic tetrahydrocannabinol. No other activity for these drug codes 
is authorized for this registration.

    Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-21334 Filed 10-1-18; 8:45 am]
 BILLING CODE 4410-09-P